• 1. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 2. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An intramolecular tryptophan-condensation approach for peptide stapling?
  Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
• 5. Acetyl protected thiol methacrylic polymers as effective ligands to keep quantum dots in luminescent standby mode?
  Marta Liras,Isabel Quijada-Garrido,Marta Palacios-Cuesta,Sonia Mu?oz-Durieux,Olga García Polym. Chem., 2014,5, 433-442

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Aralkylamines

Introduction to (5-methyl-1H-imidazol-2-yl)methanamine (CAS No. 518064-28-3)

Compound (5-methyl-1H-imidazol-2-yl)methanamine, identified by its CAS number 518064-28-3, is a significant molecule in the realm of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic amine derivative has garnered attention due to its structural versatility and potential applications in drug development. The compound features a fused imidazole ring system, which is a common motif in biologically active molecules, and a methyl-substituted nitrogen atom at the 5-position, enhancing its reactivity and functionalization possibilities.

The imidazole core is particularly noteworthy for its presence in numerous pharmacologically relevant compounds. It serves as a scaffold that can be modified to achieve specific biological activities. For instance, the imidazole ring is found in drugs targeting fungal infections, such as fluconazole, and in antiviral agents like acyclovir. The presence of a methyl group at the 2-position of the imidazole ring in (5-methyl-1H-imidazol-2-yl)methanamine introduces additional electronic and steric features that can influence its interactions with biological targets.

In recent years, there has been a surge in research focused on developing novel heterocyclic compounds for therapeutic purposes. The structural framework of (5-methyl-1H-imidazol-2-yl)methanamine makes it an attractive candidate for further exploration. Its ability to undergo various chemical transformations allows for the synthesis of more complex derivatives that could exhibit enhanced pharmacological properties. For example, functionalization at the 1-position of the imidazole ring could lead to compounds with improved solubility or bioavailability.

One of the most promising areas of research involving (5-methyl-1H-imidazol-2-yl)methanamine is its potential as a precursor for kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways, and their dysregulation is often associated with cancer and other diseases. By designing derivatives of this compound that can selectively inhibit specific kinases, researchers aim to develop new therapeutic strategies. The flexibility of the imidazole ring allows for the introduction of various substituents that can fine-tune binding affinity and selectivity.

Another avenue of investigation is the use of (5-methyl-1H-imidazol-2-yl)methanamine in the development of antimicrobial agents. The imidazole moiety has been shown to have inherent antimicrobial properties, making it a valuable component in drug design. Researchers are exploring ways to enhance these properties by synthesizing analogs that exhibit stronger activity against bacteria, fungi, and even viruses. This is particularly relevant in the context of rising antibiotic resistance, where novel antimicrobial strategies are urgently needed.

The synthesis of (5-methyl-1H-imidazol-2-yl)methanamine involves multi-step organic reactions that highlight its synthetic utility. The process typically begins with the condensation of appropriate precursors under controlled conditions to form the imidazole ring. Subsequent functionalization steps introduce the methyl group and the amine functionality at the 2-position. These synthetic routes are optimized for high yield and purity, ensuring that the final product is suitable for further pharmaceutical applications.

Advances in computational chemistry have also played a significant role in understanding the properties of (5-methyl-1H-imidazol-2-yl)methanamine. Molecular modeling techniques allow researchers to predict how this compound will interact with biological targets at the atomic level. This information is crucial for designing derivatives with improved efficacy and reduced side effects. By integrating experimental data with computational predictions, scientists can accelerate the drug discovery process and bring new treatments to market more quickly.

The pharmacokinetic profile of (5-methyl-1H-imidazol-2-yl)methanamine is another critical aspect that researchers are investigating. Understanding how this compound is absorbed, distributed, metabolized, and excreted by the body provides essential insights into its potential therapeutic applications. Studies using animal models and cell culture systems have begun to unravel these processes, paving the way for optimizing dosages and delivery methods.

In conclusion, (5-methyl-1H-imidazol-2-yl)methanamine (CAS No. 518064-28-3) represents a promising scaffold for developing novel pharmaceuticals. Its unique structural features make it suitable for applications ranging from kinase inhibition to antimicrobial therapy. Ongoing research continues to uncover new possibilities for this compound, driven by advances in synthetic chemistry, computational modeling, and pharmacological studies. As our understanding grows, so too does the potential for (5-methyl-1H-imidazol-2-yl)methanamine to contribute to next-generation therapeutics.

• 933743-52-3((2,5-dimethyl-1H-imidazol-4-yl)methanamine)
• 70807-88-4(2,4-Dimethyl-1(3)H-imidazol)
• 13400-46-9(1H-imidazol-5-ylmethanamine)
• 855250-27-0((5-Methyl-1H-imidazol-2-yl)methanamine dihydrochloride)
• 930-62-1(2,4-Dimethylimidazole)
• 858514-13-3(1H-Imidazole-4,5-dimethanamine,2-methyl-)
• 928631-39-4(1H-Imidazole-5-methanol,2-(aminomethyl)-)
• 124853-07-2([2,2'-Bi-1H-imidazole]-5,5'-dimethanamine)
• 774213-87-5(methyl(4-methyl-1H-imidazol-2-yl)methylamine)
• 88054-17-5(1H-Imidazole, 2,5-dimethyl-)